ISSN Print 2500–1094
ISSN Online 2542–1204
BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (MOSCOW, RUSSIA)
Copyright: © 2020 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
ORIGINAL RESEARCH
Dissomic disorders associated with juvenile rheumatoid arthritis: impact on quality of life
About authors
V.I. Vernadsky Crimean Federal University, Simferopol, Russia
Correspondence should be addressed: Leya E. Sorokina
Lenina boulevard, 5/7, 295006, Simferopol, Republic of Crimea; ur.liam@anikoros.ayel
About paper
Compliance with ethical standards: the study was approved by the ethical committee of the S.I. Georgievsky Medical Academy of Vernandsky Crimean Federal University (Federal State Autonomous Educational Institution), minutes protocol #9 of October 14, 2019); it was planned and conducted in accordance with the Declaration of Helsinki, with parents of all JRA patients and healthy children included in the study signing a voluntary informed consent.
Author contribution: AA Elezarov, AS Kucheryavyy — data collection, analysis and interpretation; LN Gumenyuk — research concept and design; LE Sorokina, SR Arifdzhanova, OYu Gerbali — article preparation.
Received: 2020-10-05
Accepted: 2020-10-24
Published online: 2020-11-14
|
Figure. Structure of sleep disorders, JRA patients and healthy children. DD — dyssomnic disorders; NA — nocturnal awakenings; OSDS — overall sleep duration
shortening; RAE — respiratory arrest episodes; PLM — periodic limb movements; B — bruxism; DS — daytime sleepiness; NP — no peculiarities; SI and MD — sleep
initiation and maintenance disorders; RD — respiratory disorders; SW TD — sleep-to-wakefulness transition disorders; ESD — excessive sleepiness disorders; CD —
concomitant disorders
Table 1. Comparative analysis of patients with and without sleep initiation and maintenance disorders
Note: the values are given at p < 0.05; * — p < 0.05 (significance of differences estimated with Mann–Whitney U test); ** — p < 0.01 (significance of differences estimated with Mann–Whitney U test); *** — p < 0.001 (significance of differences estimated with Mann–Whitney U test); • — p < 0.05 (significance of differences estimated with χ2 test); •• — p < 0.05 (significance of differences estimated with χ2 test); ••• — p < 0.05 (significance of differences estimated with χ2 test); n is the number of observations.
Table 2. Comparative analysis of patients with and without respiratory disorders
Note: the table shows values at p < 0.05; * — p < 0.05 (significance of differences estimated with Mann–Whitney U test); ** — p <0.01 (significance of differences estimated with Mann–Whitney U test); *** — p < 0.001 (significance of differences estimated with Mann–Whitney U test); • — p <0.05 (significance of differences estimated with χ2 test); •• — p < 0.05 (significance of differences estimated with χ2 test); n is the number of observations (here and in tables 2–4).
Table 3. Comparative analysis of patients with and without sleep-to-wakefulness transition disorders
Note: the table shows values at p < 0.05; * — p < 0.05 (significance of differences estimated with Mann–Whitney U test); ** — p < 0.01 (significance of differences estimated with Mann–Whitney U test); *** — p < 0.001 (significance of differences estimated with Mann–Whitney U test); • — p < 0.05 (significance of differences estimated with χ2 test); •• — p < 0.05 (significance of differences estimated with χ2 test); ••• — p < 0.05 (significance of differences estimated with χ2 test); n is the number of observations.
Table 4. Comparative analysis of patients with and without excessive sleepiness disorders
Note: the table shows values at p < 0.05; * — p < 0.05 (significance of differences estimated with Mann–Whitney U test); ** — p < 0.01 (significance of differences estimated with Mann–Whitney U test); *** — p < 0.001 (significance of differences estimated with Mann–Whitney U test); • — p < 0.05 (significance of differences estimated with χ2 test); •• — p <0.05 (significance of differences estimated with χ2 test); ••• — p < 0.05 (significance of differences estimated with χ2 test); n is the number of observations.
